Claudia Lewis, PA
Medical · Cleveland, OHNPI 1255065744
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Dexcom, Inc. accounts for 63.0% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2024 at $3,787 and has fallen 86.0% since, to $531 in 2025.
Across 56 payments — averaging $96.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$3K
- Sanofi-aventis U.S. LLC$475
- BETA Bionics, Inc.$225
- Novo Nordisk$211
- Lilly USA, LLC$192
- Sequel Med Tech, LLC$187
- plus $711 from 13 others
What the payments were for
- Speaking & faculty fees$2,53447%
- Travel & lodging$76614%
- Food & beverage$2,11839%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dexcom, Inc. | 9 | $3,416 |
| Sanofi-aventis U.S. LLC | 6 | $475 |
| BETA Bionics, Inc. | 1 | $225 |
| Novo Nordisk | 10 | $211 |
| Lilly USA, LLC | 10 | $192 |
| Sequel Med Tech, LLC | 4 | $187 |
| Abbott | 2 | $138 |
| Insulet Corporation | 2 | $128 |
| Ascensia Diabetes Care US Inc. | 1 | $122 |
| Mannkind Corporation | 2 | $102 |
| Corcept Therapeutics | 1 | $33 |
| Madrigal Pharmaceuticals | 1 | $29 |
| Averitas Pharma Inc. | 1 | $28 |
| Medtronic | 1 | $27 |
| Amryt Pharma Holdings Ltd | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Cequr Corporation | 1 | $24 |
| Boehringer Ingelheim | 1 | $18 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G7 GSS (161)$3,258
- iLet Bionic Pancreas$676
- TZIELD$290
- TWIIST$150
- FREESTYLE LIBRE 3$120
- Omnipod$111
How this compares
$5,417 in reported general payments places this provider in the 85th percentile of 547 medical providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 36 | $37,198 |
| JardianceEmpagliflozin | 24 | $23,957 |
| TrulicityDulaglutide | 12 | $16,654 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 26 | $14,995 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 29 | $4,001 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 13 | $3,643 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 12 | $2,227 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $1,991 |
| Easy Touch Alcohol Prep PadsAlcohol Antiseptic Pads | 18 | $204 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $211 | $37,19836 claims |
| Boehringer IngelheimJardiance | $18 | $23,95724 claims |
| Lilly USA, LLCTrulicity | $192 | $16,65412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 547 medical providers in Ohio.
Other medical in Cleveland
- Abbey BlairCleveland$24K
- Shirley YeeCleveland$6K
- Allison MartinCleveland$6K
- Salvatore BordonaroCleveland$5K
- Shannon GhizzoniColumbus$116K
- Susan WhittCanal Winchester$74K
- Christopher FrickLima$46K
- Kodi VealeAkron$43K
- Joana ZulaConcord Twp$23K
- Chelsea AustenColumbus$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.